Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$8,826,273
-$1,260,260 QoQ
Shares Held
35,075
-24.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#989
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Advisory Services, LLC holds $45,032,363 across 13 Drug Manufacturers - General names. ABBV ranks #3 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,697 | $10,431,443 | |
| 2 | JNJ |
Johnson & Johnson
|
35,778 | $9,086,538 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
35,075 | $8,826,273 | |
| 4 | PFE |
Pfizer Inc
|
200,077 | $4,817,854 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,988 | $3,853,458 | |
| 6 | AMGN |
Amgen Inc
|
8,846 | $3,203,313 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
32,911 | $1,896,331 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,218 | $785,582 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,826,273 | 35,075 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $10,086,533 | 46,377 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $10,976,431 | 48,039 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $10,996,297 | 47,492 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $9,067,722 | 48,851 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $10,398,058 | 49,628 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $6,761,840 | 38,052 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $7,616,408 | 38,568 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $6,887,385 | 40,155 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,292,558 | 40,047 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $6,538,339 | 42,191 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $6,132,030 | 41,138 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $5,603,420 | 41,590 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $6,551,381 | 41,108 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $6,923,049 | 42,838 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $4,490,129 | 33,456 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $5,194,727 | 33,917 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $5,048,591 | 31,143 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $4,150,957 | 30,657 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,169,867 | 29,386 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $3,025,059 | 26,856 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $2,936,766 | 27,137 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $2,890,156 | 26,973 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $2,202,625 | 25,147 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,749,727 | 28,007 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,121,129 | 27,840 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||